Hydrochloric Acid → HCID 46937305, 화합물
반응식
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[CH:19]=[C:18]([NH:20][S:21]([C:24]3[CH:29]=[CH:28][CH:27]=[C:26]([O:30][CH:31]([F:33])[F:32])[CH:25]=3)(=[O:23])=[O:22])[CH:17]=[CH:16][C:15]=2[CH3:34])[CH2:10][CH2:9]1)=O)(C)(C)C.[ClH:35]>ClCCl.C(OCC)C>[ClH:35].[F:33][CH:31]([F:32])[O:30][C:26]1[CH:25]=[C:24]([S:21]([NH:20][C:18]2[CH:17]=[CH:16][C:15]([CH3:34])=[C:14]([N:11]3[CH2:10][CH2:9][NH:8][CH2:13][CH2:12]3)[CH:19]=2)(=[O:22])=[O:23])[CH:29]=[CH:28][CH:27]=1참가 물질
실험 절차
4-[5-(3-Difluoromethoxy-benzenesulfonylamino)-2-methyl-phenyl]-piperazine-1-carboxylic acid tert-butyl ester (0.097 g, 0.195 mmol) was dissolved in 5 mL of dichloromethane. A solution of 0.293 mL of 2N hydrochloric acid in diethyl ether was added and the mixture stirred for 16 h at room temperature. The solvents were evaporated, the residue purified via reversed phase HPLC and fractions containing the product were combined. The pH was adjusted to 9 with aqueous sodium bicarbonate and the aqueous layer extracted with dichloromethane. The organic phase was then dried over magnesium sulphate, filtered and evaporated to dryness. The residue was treated with a solution 2N hydrochloric acid in diethyl ether and the mixture evaporated to dryness to yield the title compound (0.017 mg).
후처리
- customThe solvents were evaporated
- customthe residue purified via reversed phase HPLC and fractions
- additioncontaining the product
- extractionthe aqueous layer extracted with dichloromethane
- dry with materialThe organic phase was then dried over magnesium sulphate
- filtrationfiltered
- customevaporated to dryness
- additionThe residue was treated with a solution 2N hydrochloric acid in diethyl ether
- customthe mixture evaporated to dryness
출처 및 근거
- ORD 기록
- ord-f2e20cd6da63464ea2e9c6762fa0052f
- 출처 데이터셋
- uspto-grants-2012_05
- 특허 번호
- US08183237B2
반응 노트
불러오는 중…